Cria, Inc.

Cria, Inc. is an institutional investment manager that reports U.S. equity holdings to the U.S. Securities and Exchange Commission on Form 13F under CIK 0002065494. Organized as a corporation ("Inc."), the firm functions as a dedicated investment vehicle rather than as an operating company with a primary non‑financial business line. Its Form 13F status confirms that it exercises investment discretion over portfolios containing U.S.-listed equities and equity‑linked instruments above the SEC’s reporting thresholds. Public secondary sources provide only limited narrative detail on Cria, Inc.’s headquarters location, founding date, ownership, or key principals. Those elements are typically set out in Form ADV (where applicable), offering documents, and corporate filings rather than in Form 13F itself. What is clearly established is the firm’s role as an institutional investment manager whose long U.S. positions are visible in the 13F reporting regime. Within an advanced analytics platform, all filings under CIK 0002065494 can be organized into a continuous 13F History for Cria, Inc. This creates a structured, time‑series record of disclosed holdings that can be analyzed for concentration, sector exposure, and portfolio evolution. The platform’s role is strictly secondary: it aggregates and interprets the firm’s own SEC disclosures and does not replace primary documents as the factual source on Cria, Inc.’s structure or governance.

Cria, Inc. does not appear with extensive marketing material or strategy descriptions in major public databases, so the most reliable view of its approach comes from its disclosed holdings. As a 13F filer, the firm manages a long U.S. equity book; any additional activity in non‑U.S. securities, private assets, short positions, or derivatives would not be captured in Form 13F. Institutional managers with a similar profile typically pursue fundamentally driven public‑equity strategies. Portfolios are often composed of a curated list of single‑name positions, potentially complemented by exchange‑traded funds or other listed vehicles for tactical or hedging purposes. Position sizes usually reflect conviction level, liquidity, and risk budgeting constraints. For Cria, Inc., the observable implementation is embodied in its 13F Portfolio Composition from one quarter to the next. Key characteristics that allocators can evaluate directly from those filings include: - Breadth of the book: the number of positions and how capital is distributed among them. - Concentration: the weight carried by the largest holdings and how persistent those top positions are over time. - Sector and factor footprints: recurring exposure to particular industries or themes, and implied style tilts (growth, value, quality) inferred from the mix of holdings. Because 13F reports are limited to long U.S.-listed positions and are reported with a lag, they provide a partial and backward‑looking window into the strategy. To translate these holdings into an approximate picture of Cria, Inc.’s capital trajectory, a Backtesting Service can construct a 13F‑based Historical Track Record under transparent assumptions about quarter‑end rebalancing and pricing. A Portfolio Simulator can then run Performance Backtests Online against relevant benchmarks, turning static holdings snapshots into a dynamic view of how the visible long book would have compounded over time.

Cria, Inc., reporting as an institutional investment manager under SEC CIK 0002065494, is a corporate investment platform whose Form 13F disclosures provide a verifiable, position‑level record of its long U.S. equity exposures. While public narrative on its origins, team, and explicit mandate is limited, the holdings data furnish a solid empirical foundation for analyzing how the firm has deployed capital in U.S.-listed equities across different market environments. By aggregating its filings into a structured 13F History and applying an analytics layer, allocators can convert Cria, Inc.’s disclosed holdings into a reconstructed capital path, track changes in 13F Portfolio Composition, and derive key diagnostics such as Max Drawdown Depth and the Sharpe Ratio from a 13F‑based Historical Track Record. These tools, accessed via a Backtesting Service and Portfolio Simulator, offer an independent, holdings‑driven perspective on the concentration, style exposures, and regime behavior of the firm’s observable long‑equity sleeve. The central diagnostic question for allocators is how that reconstructed capital trajectory responds to shifting regimes: as markets rotate between growth and value leadership, risk‑on and risk‑off phases, and changing interest‑rate and volatility backdrops, does Cria, Inc.’s 13F‑implied portfolio appear robust and process‑driven, or does it exhibit regime sensitivity that would need to be explicitly managed within a broader multi‑manager or multi‑asset allocation?

The risk profile of Cria, Inc., as it can be inferred from public data, is that of an actively managed long U.S. equity portfolio. While the firm’s total economic risk may also be shaped by instruments and exposures not captured in Form 13F, the filings support a disciplined assessment of the observable long‑equity sleeve. From the 13F history under CIK 0002065494, allocators can evaluate several key risk dimensions: - Concentration risk: the percentage of reconstructed capital residing in the largest positions. A narrow set of high‑conviction holdings implies greater idiosyncratic risk than a broadly diversified roster. - Sector and style tilts: systematic overweights or underweights to particular industries or factors, which influence sensitivity to macro regimes, factor rotations, and thematic shocks. - Turnover and holding‑period discipline: the magnitude of quarter‑to‑quarter changes in positions and position sizes, signaling whether the strategy leans toward long‑horizon compounding or more frequent repositioning around catalysts. By linking sequential filings into a holdings‑based equity curve, an analytics engine can quantify downside and variability characteristics for Cria, Inc.’s observable book. Max Drawdown Depth on this reconstructed trajectory measures the worst peak‑to‑trough decline over the analysis window, highlighting how the long U.S. sleeve would have behaved during stress episodes. A Sharpe Ratio calculated on the same series summarizes the balance between excess growth over a reference rate or benchmark and the volatility of that path, providing a compact view of risk‑adjusted outcomes for the portion of the portfolio visible in 13F. These statistics should be interpreted with care. They exclude any short positions, derivatives overlays, private assets, or non‑U.S. securities that may be embedded in Cria, Inc.’s full mandate, and they do not capture intraperiod trading activity. As such, 13F‑based risk analytics are best used as one input among many in a comprehensive risk assessment that also draws on manager‑provided data and offering materials.